Inmune Bio Files 8-K: Financials & Exhibits
Ticker: INMB · Form: 8-K · Filed: Mar 24, 2025 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 8-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, exhibits, reporting
Related Tickers: INMB
TL;DR
INMB filed an 8-K for financials, nothing major to see here.
AI Summary
On March 24, 2025, Inmune Bio, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other significant business updates detailed in the provided text. The company is incorporated in Nevada and its principal executive offices are located in Boca Raton, Florida.
Why It Matters
This filing indicates Inmune Bio, Inc. is meeting its reporting obligations by submitting financial statements and exhibits, which is standard procedure for public companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, indicating standard corporate reporting rather than a material event.
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- March 24, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- Boca Raton, Florida (location) — Address of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Inmune Bio, Inc.?
The primary purpose of this 8-K filing is to report financial statements and exhibits, as indicated by the 'ITEM INFORMATION: Financial Statements and Exhibits' section.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 24, 2025.
In which U.S. state is Inmune Bio, Inc. incorporated?
Inmune Bio, Inc. is incorporated in Nevada.
What is the business address of Inmune Bio, Inc.?
The business address of Inmune Bio, Inc. is 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432.
Does this 8-K filing report any specific material events or other significant business updates?
Based on the provided text, this 8-K filing primarily concerns financial statements and exhibits and does not detail any specific material events or other significant business updates.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 24, 2025 regarding Inmune Bio, Inc. (INMB).